CORONA Remedies Limited (CORONA) — Board Meeting | 10 July 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

CORONA Remedies Limited announced the e-voting results and Scrutinizer Report for its 22nd Annual General Meeting held on July 9, 2026, where all proposed resolutions were approved, including the adoption of audited financial statements, declaration of a final dividend of ₹10 per share, appointment of directors, and auditor appointments. The voting took place remotely from July 6 to 8, 2026, with additional e-voting during and after the meeting, and all results are available on the company's website and CDSL portal.

📄 View Original Announcement (PDF)

About CORONA Remedies Limited (CORONA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹10,869.98 Cr

View full CORONA stock details →

📡 Get AI alerts when CORONA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CORONA — Free

📊 More CORONA filings

See all CORONA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CORONA files new disclosures

Track CORONA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CORONA — Free

Free account · 2 AI queries/day